MiR-21, as a typical noncoding RNA targeting at PTEN, indirectly activates NF-κB signaling in CRC cells via the PI3K–AKT pathway, and ultimately promotes the proliferation of tumor cells [60]. The gene discussed is PTEN; the disease is neoplasm.